Integrative Treatment Methods in COVID-19

October 20, 2021 updated by: nurhandogan, Amasya University

Examination of the Use of Integrative Treatment Methods by Individuals Undergoing COVID-19 Acording to the Health Promotion Model: a Sample Qualitative Study

This study was conducted to examine the use of integrative treatment methods by individuals undergoing Covid-19. In this study, which was designed in the qualitative and phenomenological type, the criterion sampling method was used and 12 people were included in the sample.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

This study was a qualitative type of phenomenological study conducted to examine the use of integrative treatment methods by individuals undergoing Covid-19. The study was completed with 12 people. The data were collected between July and October 2021. The interviews lasted for an average of 25-30 minutes. The data collected with the semi-structured interview form were analyzed by descriptive content analysis method after the interviews were over.

Study Type

Observational

Enrollment (Actual)

12

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Turkey
      • Amasya, Turkey, 05100
        • Amasya University Sciences Faculty

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Individuals who underwent Covid-19 and used any of the integrative treatment methods constituted the population of the study. Using the criterion sampling method, individuals who underwent Covid-19 and used any of the integrative treatment methods and agreed to participate in the study constituted the sample group. In accordance with the nature of qualitative research, the study was completed with 12 people.

Description

Inclusion Criteria:

  • individuals who underwent Covid-19 and used any of the integrative treatment methods
  • agreed to participate in the study constituted the sample group.

Exclusion Criteria:

-

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Individuals with Covid-19
Interviews were conducted with individuals who had Covid-19, and their experiences with the integrative methods they used were determined.
Other: focus interview
The "Information Form" including descriptive characteristics of the individuals undergoing Covid-19, the semi-structured "Interview Form", and the Complementary Therapy Use Form were used as the data collection tools. The Information Form consisted of 13 questions including socio-demographic and disease-related characteristics of individuals. In-depth interview method was used to collect data. Interviews were held by organizing video calls and online meeting programs on mobile phones both due to pandemic measures and in order to enable individuals to communicate comfortably. The time period in which the individuals felt most ready for the interview was determined and the data were collected during that time. During the interview, effective communication techniques were used, active listening was carried out and individuals were guided using question forms in accordance with the aim of the study. The interviews lasted for an average of 25-30 minutes.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Using integrative treatment method
Time Frame: 15 July- October 2021
All participants included in the study had used at least one of the integrative treatment methods.
15 July- October 2021
Kind of integrative treatment methods
Time Frame: October 2021
It was determined that vitamin C and medicinal plants were frequently used in addition to their medical treatments.
October 2021

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Amasya University

Investigators

  • Principal Investigator: Gamze Fıskın, PhD, Amasya University
  • Principal Investigator: Nurhan Dogan, PhD, Amasya University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

July 15, 2021

Primary Completion (Actual)

October 15, 2021

Study Completion (Actual)

October 15, 2021

Study Registration Dates

First Submitted

October 20, 2021

First Submitted That Met QC Criteria

October 20, 2021

First Posted (Actual)

October 22, 2021

Study Record Updates

Last Update Posted (Actual)

October 22, 2021

Last Update Submitted That Met QC Criteria

October 20, 2021

Last Verified

October 1, 2021

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • Amasya U-2

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on COVID-19

Clinical Trials on focus interview

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in United Kingdom

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe